Warnings
CBDA (2.8%); Free CBD (6.2%); CBD (8.7%); CBN (0.7%); Free THC (14.4%); THCA (0.1%); THC (14.5%); Delta-8-THC
检测到 CBDA 2.8%, Free CBD 6.2%, CBD 8.7%, CBN 0.7%, Free THC 14.4%, THCA 0.1%, THC 14.5%, d-8-四氢大麻酚。 地点:Zürich, 瑞士。 日期:2026-03-11。 来源:saferparty.ch。
CBDA (2.8%); Free CBD (6.2%); CBD (8.7%); CBN (0.7%); Free THC (14.4%); THCA (0.1%); THC (14.5%); Delta-8-THC 药丸 — Zürich, 瑞士 — 2026-03-11
- Detected
- CBDA 2.8%, Free CBD 6.2%, CBD 8.7%, CBN 0.7%, Free THC 14.4%, THCA 0.1%, THC 14.5%, Delta-8-THC
- Expected
- Unknown
- Logo
- Unknown
- Color
- brown
- Location
- Zürich, Switzerland
- Date
- 2026-03-11
- Source
- saferparty.ch
- Media
- 1 image
Appearance
- Color: brown
- Media: 1 sample photo
Detected Substances
- CBDA 2.8%
- Free CBD 6.2%
- CBD 8.7%
- CBN 0.7%
- Free THC 14.4%
- THCA 0.1%
- THC 14.5%
- Delta-8-THC
Expected vs Detected
No expected substance was recorded for this sample.
Detected result: CBDA 2.8%, Free CBD 6.2%, CBD 8.7%, CBN 0.7%, Free THC 14.4%, THCA 0.1%, THC 14.5%, Delta-8-THC
Sample Details
No additional sample descriptors available.
Testing Context
- Location: Zürich, 瑞士
- Date tested: 2026-03-11
- Source: saferparty.ch
Harm Reduction
- Similar-looking pills can contain different substances or strengths.
- Use drug checking services when available.
- Start low and avoid assuming a logo identifies the contents.
SampleDNA Beta
406 条相关警告 · 了解常见杂质的更多信息。
- CBDA2.8%
- Free CBD6.2%
- CBD8.7%
- CBN0.7%
- Free THC14.4%
- THCA0.1%
- THC14.5%
- Delta-8-THC检测到
相关样本和组合
CBD + CBDA + CBN + Delta-8-THC + Free CBD + Free THC + THC + THCA
3 份样本 · 当前结果
在相关药物检测结果中共同检测到。
CBD + CBDA + CBN + Delta-8-THC + Free CBD + Free THC + MDMB-PINACA + THC + THCA
1 份样本
在相关药物检测结果中共同检测到。
CBD + CBDA + CBN + Delta-8-THC + Free CBD + Free THC + THC
1 份样本
在相关药物检测结果中共同检测到。
5F-ADB + CBD + CBDA + Free CBD + Free THC + THC + THCA
2 份样本
在相关药物检测结果中共同检测到。
CBD + CBDA + Delta-8-THC + Free CBD + Free THC + THC
2 份样本
在相关药物检测结果中共同检测到。
SampleDNA 探索器
Links
This static page is intended as the readable export baseline for crawler and low-capability delivery.